Last edition
News about "Hikma Pharmaceuticals "
Hikma Welcomes FDA Approval of Guardant360 Liquid CDx, Expanding Precision Cancer Diagnostics
The FDA-approved Guardant360 Liquid CDx enables advanced cancer biomarker testing through a simple blood draw, supporting faster and more precise treatment decisions.
Hikma Pharmaceuticals | 25/06/2026 | By News Bureau
Pfizer Reaches Three Settlement Deals for VYNDAMAX
Pfizer reaches three settlement agreements for VYNDAMAX, extending US patent exclusivity to June 1, 2031, subject to the outcome of other litigation.
Hikma Pharmaceuticals | 30/04/2026 | By News Bureau | 215
Hikma, Celltrion Deepen Ties to Boost Biosimilar Access in Middle East and North Africa
British multinational pharmaceutical company Hikma Pharmaceuticals has signed new exclusive licensing agreements with its long-standing partner, South Korea’s Celltrion, covering the Middle East and North Africa (MENA) region.
Hikma Pharmaceuticals | 06/10/2025 | By Dineshwori | 360
Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing
Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing
Hikma Pharmaceuticals | 18/08/2023 | By Sudeep Soparkar | 1104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy